Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicament combination for preventing and treating canine/feline magnesium ammonium phosphate stones, and preparation method thereof

A technology for ammonium phosphate and magnesium lithiasis, which is applied in the direction of drug combinations, pharmaceutical formulas, active ingredients of hydroxyl compounds, etc., can solve the problems of high price and difficulty in sales, increase peristalsis frequency, reduce urea decomposition, and prevent and control ammonium magnesium phosphate stones Effect

Inactive Publication Date: 2010-03-10
TIANJIN SHENGJI GRP CO LTD
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Some foreign pet food companies have developed a series of prescription diets for the prevention and treatment of dog and cat stones, but the price is generally high and it is difficult to widely sell them

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] A pharmaceutical composition for preventing and treating calculus of ammonium magnesium phosphate in dogs and cats, which is characterized in that it is formed by uniformly mixing the following active ingredients according to weight or unit ratio: 13g of desmodium and Haijinsha granules; 0.3g of acetohydroxylamine; vitamin A 4000IU .

[0019] The implementation steps of the preparation method are as follows: according to the ratio of parts by weight, take Desmodium chinensis: Haijinsha=10:3, such as taking 1000g of Desmodium, and 300g of Haijinsha, decocting the above-mentioned medicines in water for three times, filtering them respectively, and combining the filtrates, and then heating and concentrating the filtrates. Conventional granulation, each gram of granules contains 1g of crude drug; that is to make 1300g of granules; then take 13-39g of desmodium and sea gold sand granules, 0.3g of acetohydroxylamine, and 4000IU of vitamin A and mix evenly.

[0020] The above-...

Embodiment 2

[0022] A pharmaceutical composition for preventing and treating calculus of ammonium magnesium phosphate in dogs and cats, which is characterized in that it is formed by uniformly mixing the following active ingredients according to weight or unit ratio: 26g of Desmodium and Haijinsha granules; 0.3g of acetohydroxylamine; vitamin A 4000IU . Others are with embodiment 1.

Embodiment 3

[0024] A pharmaceutical composition for preventing and treating calculus of ammonium magnesium phosphate in dogs and cats, which is characterized in that it is formed by uniformly mixing the following active ingredients according to weight or unit ratio: 39g of desmodium and Haijinsha granules; 0.3g of acetohydroxylamine; vitamin A 4000IU . Others are with embodiment 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicinal composition for preventing and treating canine / feline magnesium ammonium phosphate stones, and a preparation method thereof. The composition is prepared by evenlymixing the following effective components in ratio by weight or unit: 13 to 39 grams of lysimachia nummularia and lygodium japonicum granules, 0.3 gram of acetohydroxamic acid and 4,000 IU of vitaminA. The medicinal composition for preventing and treating canine / feline magnesium ammonium phosphate stones is added as a unit for each kilogram of canine / feline feed. In the invention, lysimachia nummularia promotes urination and treats stranguria, while lygodium japonicum clears heat, promotes urination, treats stranguria and relieves pain, and both the lysimachia nummularia and the lygodium japonicum can increase the frequency of ureteral peristalsis, raise the pressure in ureteral upper-section cavities and play a significant role in promoting urination and eliminating stones; meanwhile, the agent utilizes the characteristic of inhibiting urease activity through acetohydroxamic acid to reduce the ammonia concentration and pH of urine and prevent the formation of infectious urinary stones or inhibit the growth thereof; and the vitamin A is utilized to maintain the integrity of urinary-tract epithelium so as to realize the activity of crystallization inhibitors and inhibit crystallization. The agent jointly uses medicaments from different angles to eliminate the inducing factors of stones and plays a definite role in preventing magnesium ammonium phosphate stones.

Description

technical field [0001] The invention relates to a medicine for preventing and treating calculus in dogs and cats and a preparation method thereof, in particular to a pharmaceutical composition for preventing and treating calculus of ammonium magnesium phosphate in dogs and cats and a preparation method thereof. Background technique [0002] In recent years, dogs and cats have become the mainstream of pets, and working dogs and meat dogs have driven the development of the entire dog industry. In the breeding and management of dogs and cats, disease is the most important link that affects the health of dogs and cats. Among them, dog and cat urolithiasis is the most common urinary system disease in dogs and cats. According to domestic and foreign research data, its clinical incidence rate is 0.5-1.0%, and the recurrence rate of urolithiasis within two years after treatment can be as high as 50%. . The pathogenesis of stones is complicated, and there are many types of stones, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/53A61P13/04A61K31/07A61K31/16
Inventor 王金勇王连民
Owner TIANJIN SHENGJI GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products